BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garrido I, Liberal R, Macedo G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment Pharmacol Ther. 2020;52:267-275. [PMID: 32402090 DOI: 10.1111/apt.15813] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 31.0] [Reference Citation Analysis]
Number Citing Articles
1 Testino G, Vignoli T, Patussi V, Allosio P, Amendola MF, Aricò S, Baselice A, Balbinot P, Campanile V, Fanucchi T, Greco G, Macciò L, Meneguzzi C, Mioni D, Palmieri VO, Parisi M, Renzetti D, Rossin R, Gandin C, Bottaro LC, Bernardi M, Addolorato G, Lungaro L, Zoli G, Scafato E, Caputo F. Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA). Dig Dis Sci 2021. [PMID: 34142284 DOI: 10.1007/s10620-021-07006-1] [Reference Citation Analysis]
2 Sikkema BJB, Sint Nicolaas JJ, van Wijngaarden PP. No association between COVID-19 related liver injury and the course of disease: a retrospective study. Scand J Gastroenterol 2021;56:68-71. [PMID: 33119428 DOI: 10.1080/00365521.2020.1842489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 An Y, Ma Z, Guo X, Tang Y, Meng H, Yu H, Peng C, Chu G, Wang X, Teng Y, Zhang Q, Zhu T, Wang B, Tong Z, Zhao H, Lu H, Qi X. Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational study. Medicine (Baltimore) 2021;100:e25497. [PMID: 34106589 DOI: 10.1097/MD.0000000000025497] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bzeizi K, Abdulla M, Mohammed N, Alqamish J, Jamshidi N, Broering D. Effect of COVID-19 on liver abnormalities: a systematic review and meta-analysis. Sci Rep 2021;11:10599. [PMID: 34012016 DOI: 10.1038/s41598-021-89513-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Drakoulis N, Porter AL, Tsatsakis A, Spandidos DA. Contributing factors common to COVID‑19 and gastrointestinal cancer. Oncol Rep 2022;47:16. [PMID: 34779496 DOI: 10.3892/or.2021.8227] [Reference Citation Analysis]
7 Assa A, Benninga MA, Borrelli O, Broekaert I, de Carpi JM, Saccomani MD, Dolinsek J, Mas E, Miele E, Thomson M, Tzivinikos C; Gastrointestinal Committee of ESPGHAN. Gastrointestinal Perspective of Coronavirus Disease 2019 in Children-An Updated Review. J Pediatr Gastroenterol Nutr 2021;73:299-305. [PMID: 34117195 DOI: 10.1097/MPG.0000000000003204] [Reference Citation Analysis]
8 Przekop D, Gruszewska E, Chrostek L. Liver function in COVID-19 infection . World J Hepatol 2021; 13(12): 1909-1918 [DOI: 10.4254/wjh.v13.i12.1909] [Reference Citation Analysis]
9 Al-Nimer MS. Is COVID-19-induced liver injury different from other RNA viruses?‎ World J Meta-Anal 2021; 9(2): 108-127 [DOI: 10.13105/wjma.v9.i2.108] [Reference Citation Analysis]
10 Sin P, Díaz LA, Martínez M, Vizcaya C, D'Agostino D, Gana JC. Acute Liver Injury Among Pediatric Liver Transplantation Recipients With Coronavirus Disease 2019: An International Collaborative Study. J Pediatr Gastroenterol Nutr 2021;73:391-4. [PMID: 34183614 DOI: 10.1097/MPG.0000000000003213] [Reference Citation Analysis]
11 Lin H, Wu LJ, Guo SQ, Chen RL, Fan JR, Ke B, Pan ZQ. Dynamic monitoring of serum liver function indexes in patients with COVID-19. World J Clin Cases 2021; 9(7): 1554-1562 [PMID: 33728299 DOI: 10.12998/wjcc.v9.i7.1554] [Reference Citation Analysis]
12 Xiang F, Sun J, Chen PH, Han P, Zheng H, Cai S, Kirk GD. Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019. Clin Infect Dis 2021;73:e594-601. [PMID: 33909004 DOI: 10.1093/cid/ciaa1710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zinellu A, Arru F, De Vito A, Sassu A, Valdes G, Scano V, Zinellu E, Perra R, Madeddu G, Carru C, Pirina P, Mangoni AA, Babudieri S, Fois AG. The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients. Eur J Clin Invest 2021;51:e13427. [PMID: 33043447 DOI: 10.1111/eci.13427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
14 Ozkurt Z, Çınar Tanrıverdi E. COVID-19: Gastrointestinal manifestations, liver injury and recommendations. World J Clin Cases 2022; 10(4): 1140-1163 [DOI: 10.12998/wjcc.v10.i4.1140] [Reference Citation Analysis]
15 Liu Y, Wang K, Massoud TF, Paulmurugan R. SARS-CoV-2 Vaccine Development: An Overview and Perspectives. ACS Pharmacol Transl Sci 2020;3:844-58. [PMID: 33062951 DOI: 10.1021/acsptsci.0c00109] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
16 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Mnatsakanyan MG, Pogromov AP, Lishuta AS, Fomin VV, Volkova OS, Tashchyan OV, Kuprina IV, Shumskaya YF. Liver and COVID-19: possible mechanisms of damage. Terapevticheskii arkhiv 2021;93:427-30. [DOI: 10.26442/00403660.2021.04.200733] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kumar A, Kumar P, Dungdung A, Kumar Gupta A, Anurag A, Kumar A. Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients. Diabetes Metab Syndr. 2020;14:1951-1954. [PMID: 33039937 DOI: 10.1016/j.dsx.2020.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
19 Basu A, Pamreddy A, Singh P, Sharma K. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models. J Mol Biol 2021;:167213. [PMID: 34437890 DOI: 10.1016/j.jmb.2021.167213] [Reference Citation Analysis]
20 Philips CA, Kakkar K, Joseph M, Yerol PK, Ahamed R, Rajesh S, Augustine P. Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care. J Clin Transl Hepatol 2021;9:576-86. [PMID: 34447688 DOI: 10.14218/JCTH.2020.00110] [Reference Citation Analysis]
21 Grace JA, Casey S, Burrell LM, Angus PW. Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis. Hepatol Int. 2020;14:884-885. [PMID: 32886332 DOI: 10.1007/s12072-020-10084-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
22 de Oliveira VM, da Rocha MN, Magalhães EP, da Silva Mendes FR, Marinho MM, de Menezes RRPPB, Sampaio TL, Dos Santos HS, Martins AMC, Marinho ES. Computational approach towards the design of artemisinin-thymoquinone hybrids against main protease of SARS-COV-2. Futur J Pharm Sci 2021;7:185. [PMID: 34514004 DOI: 10.1186/s43094-021-00334-z] [Reference Citation Analysis]
23 Afaghi P, Lapolla MA, Ghandi K. Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients. Heliyon 2021;7:e06454. [PMID: 33748501 DOI: 10.1016/j.heliyon.2021.e06454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 İnanç İ, Erdemli E. Histopathological features of SARS-CoV-2 infection and relationships with organoid technology. J Int Med Res 2021;49:3000605211044382. [PMID: 34521239 DOI: 10.1177/03000605211044382] [Reference Citation Analysis]
25 Lv Y, Zhao X, Wang Y, Zhu J, Ma C, Feng X, Ma Y, Zheng Y, Yang L, Han G, Xie H. Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19. Front Med (Lausanne) 2021;8:639855. [PMID: 34179034 DOI: 10.3389/fmed.2021.639855] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Ali A, Hasan M, Hamed S, Elhamy A. Hepatic steatosis: a risk factor for increased COVID-19 prevalence and severity-a computed tomography study. Egypt Liver J 2021;11:61. [PMID: 34777870 DOI: 10.1186/s43066-021-00131-6] [Reference Citation Analysis]
27 Jeon D, Son M, Choi J. Impact of Liver Cirrhosis on the Clinical Outcomes of Patients with COVID-19: A Nationwide Cohort Study of Korea. Korean J Intern Med. [DOI: 10.3904/kjim.2020.486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Voiosu A, Roman A, Pop R, Boeriu A, Popp C, Zurac S, Voiosu T, Dobru D, Mateescu B. Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experience. Rom J Intern Med 2021. [PMID: 34253002 DOI: 10.2478/rjim-2021-0027] [Reference Citation Analysis]
29 Yadlapati S, Lo KB, DeJoy R, Gul F, Peterson E, Bhargav R, Salacup GF, Pelayo J, Azmaiparashvilli Z, Patarroyo-Aponte G. Prevailing patterns of liver enzymes in patients with COVID-19 infection and association with clinical outcomes. Ann Gastroenterol 2021;34:224-8. [PMID: 33654363 DOI: 10.20524/aog.2021.0573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ferron PJ, Gicquel T, Mégarbane B, Clément B, Fromenty B. Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury? Biochimie 2020;179:266-74. [PMID: 32891697 DOI: 10.1016/j.biochi.2020.08.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
31 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in Crossref: 36] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
32 McDermott CV, Cox EJ, Scanlan JM, Alicic RZ. COVID-19 and Gastrointestinal Tract Symptoms: Recognition, Containment, and Learning From the Past. Mayo Clin Proc 2020;95:2320-4. [PMID: 33153620 DOI: 10.1016/j.mayocp.2020.08.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
33 Alves AM, Yvamoto EY, Marzinotto MAN, Teixeira ACS, Carrilho FJ. SARS-CoV-2 leading to acute pancreatitis: an unusual presentation. Braz J Infect Dis 2020;24:561-4. [PMID: 32961108 DOI: 10.1016/j.bjid.2020.08.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
34 Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Brüggen MC, van de Veen W, Sokolowska M, Akdis M, Akdis CA. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy 2021;76:428-55. [PMID: 33185910 DOI: 10.1111/all.14657] [Cited by in Crossref: 282] [Cited by in F6Publishing: 180] [Article Influence: 282.0] [Reference Citation Analysis]
35 Pellegrini JR Jr, Sabbula B, Russe-Russe JR, Munshi RF, Meshoyrer D, Sajid N, Gutierrez A, Munnangi S, Szydziak E, Akella J. A Retrospective Analysis of COVID-19-infected Patients with Acute Hepatitis who Develop Acute Liver Failure in a Safety Net Hospital. BMJ Open Gastroenterol 2021;8:e000738. [PMID: 34810216 DOI: 10.1136/bmjgast-2021-000738] [Reference Citation Analysis]
36 D'Amico FE, Glavas D, Noaro G, Bassi D, Boetto R, Gringeri E, De Luca M, Cillo U. Case Report: Liver Cysts and SARS-CoV-2: No Evidence of Virus in Cystic Fluid. Front Surg 2021;8:677889. [PMID: 34222319 DOI: 10.3389/fsurg.2021.677889] [Reference Citation Analysis]
37 Huang W, Zhou H, Hodgkinson C, Montero A, Goldman D, Chang SL. Network Meta-Analysis on the Mechanisms Underlying Alcohol Augmentation of COVID-19 Pathologies. Alcohol Clin Exp Res 2021;45:675-88. [PMID: 33583045 DOI: 10.1111/acer.14573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
38 Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. J Mol Histol. 2020;51:613-628. [PMID: 33011887 DOI: 10.1007/s10735-020-09915-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 30.5] [Reference Citation Analysis]
39 Di Giorgio A, Hartleif S, Warner S, Kelly D. COVID-19 in Children With Liver Disease. Front Pediatr 2021;9:616381. [PMID: 33777864 DOI: 10.3389/fped.2021.616381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Abe K, Yamamoto T, Matsumoto K, Kikuchi K, Miura R, Tachizawa N, Asaoka Y, Takezawa T, Matsunaga N, Obi S, Tanaka A. Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population. Intern Med. 2020;59:2353-2358. [PMID: 32999264 DOI: 10.2169/internalmedicine.5777-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R, Talukdar R, Sharma M, Qi X, Rao PN, Reddy DN. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020;52:584-599. [PMID: 32638436 DOI: 10.1111/apt.15916] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 29.5] [Reference Citation Analysis]
42 Xiang TD, Zheng X. Interaction between hepatitis B virus and SARS-CoV-2 infections. World J Gastroenterol 2021; 27(9): 782-793 [PMID: 33727770 DOI: 10.3748/wjg.v27.i9.782] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
43 Cîrstea AE, Buzulică RL, Pirici D, Ceauşu MC, Iman RV, Gheorghe OM, Neamţu SD, Stanca L, Ene R, Kumar-Singh S, Mogoantă L. Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection. Rom J Morphol Embryol 2020;61:209-18. [PMID: 32747912 DOI: 10.47162/RJME.61.1.23] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
44 Ali N, Hossain K. Liver injury in severe COVID-19 infection: current insights and challenges. Expert Rev Gastroenterol Hepatol. 2020;14:879-884. [PMID: 32649840 DOI: 10.1080/17474124.2020.1794812] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
45 Ali FEM, Mohammedsaleh ZM, Ali MM, Ghogar OM. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World J Gastroenterol 2021; 27(15): 1531-1552 [PMID: 33958841 DOI: 10.3748/wjg.v27.i15.1531] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Wang B, Dong X, Hu J, Ma X, Han C, Wang Y, Gao L. The peripheral and core regions of virus-host network of COVID-19. Brief Bioinform 2021:bbab169. [PMID: 33956950 DOI: 10.1093/bib/bbab169] [Reference Citation Analysis]
47 Goodall JW, Reed TAN, Ardissino M, Bassett P, Whittington AM, Cohen DL, Vaid N. Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study. Epidemiol Infect 2020;148:e251. [PMID: 33046155 DOI: 10.1017/S0950268820002472] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
48 Levy E, Stintzi A, Cohen A, Desjardins Y, Marette A, Spahis S. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19. Am J Physiol Gastrointest Liver Physiol 2021;321:G99-G112. [PMID: 34009033 DOI: 10.1152/ajpgi.00106.2021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
49 Nathwani R, Mukherjee S, Forlano R, Mullish BH, Vergis N, Selvapatt N, Manousou P, Nayagam S, Lemoine M, Dhar A. Letter: liver disease and COVID-19-not the perfect storm. Aliment Pharmacol Ther 2020;52:572-4. [PMID: 32656833 DOI: 10.1111/apt.15872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Shousha HI, Ramadan A, Lithy R, El-Kassas M. Patterns of liver profile disturbance in patients with COVID-19 . World J Clin Cases 2022; 10(7): 2063-2071 [DOI: 10.12998/wjcc.v10.i7.2063] [Reference Citation Analysis]
51 Eisa M, Kennedy R, Teferra R, Heckroth M, Eiswerth M, McClain C. SARS-COV-2 Infection in Patients With Alcohol-Associated Hepatitis: Metabolic Similarities and Treatment Challenges. Am J Gastroenterol 2021;116:847-8. [PMID: 33982972 DOI: 10.14309/ajg.0000000000001002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 [DOI: 10.1101/2020.04.01.20048561] [Cited by in Crossref: 66] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
53 Mousaad Elemam N, Hannawi H, Bin Naeem K, Hannawi S. A single centered study reveals association between liver injury and COVID-19 infection. Saudi J Biol Sci 2021. [PMID: 34220212 DOI: 10.1016/j.sjbs.2021.06.064] [Reference Citation Analysis]
54 Alyammahi SK, Abdin SM, Alhamad DW, Elgendy SM, Altell AT, Omar HA. The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities. Infect Genet Evol 2021;87:104647. [PMID: 33264669 DOI: 10.1016/j.meegid.2020.104647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
55 Parlak S, Çıvgın E, Beşler MS, Kayıpmaz AE. The effect of hepatic steatosis on COVID-19 severity: Chest computed tomography findings. Saudi J Gastroenterol 2021;27:105-10. [PMID: 33642355 DOI: 10.4103/sjg.sjg_540_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 McConnell MJ, Kondo R, Kawaguchi N, Iwakiri Y. Covid-19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis. Hepatol Commun 2021. [PMID: 34658172 DOI: 10.1002/hep4.1843] [Reference Citation Analysis]
57 Ali N. Relationship Between COVID-19 Infection and Liver Injury: A Review of Recent Data. Front Med (Lausanne) 2020;7:458. [PMID: 32793619 DOI: 10.3389/fmed.2020.00458] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
58 Melo AKG, Milby KM, Caparroz ALMA, Pinto ACPN, Santos RRP, Rocha AP, Ferreira GA, Souza VA, Valadares LDA, Vieira RMRA, Pileggi GS, Trevisani VFM. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis. PLoS One 2021;16:e0253894. [PMID: 34185801 DOI: 10.1371/journal.pone.0253894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
59 Zhai G, Li M, Wang Y, Wu J. Drug-Induced Liver Disturbance During the Treatment of COVID-19. Front Pharmacol 2021;12:719308. [PMID: 34483929 DOI: 10.3389/fphar.2021.719308] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Wang Q, Davis PB, Xu R. COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States. EClinicalMedicine. 2021;31:100688. [PMID: 33521611 DOI: 10.1016/j.eclinm.2020.100688] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
61 Wang Y, Lu F, Zhao J. Reply to: Correspondence relating to "SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19". J Hepatol 2020;73:996-8. [PMID: 32589896 DOI: 10.1016/j.jhep.2020.06.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
62 Qaisieh R, Al-Tamimi M, El-Hammuri N, Shalabi M, Kilani MM, Taha H, Al-Muhtaseb A, Alfarrajin I, Abu Shaqra M, Hamdan A. Comparative study of Clinical, Laboratory, and Imaging Features of COVID-19. JMIR Public Health Surveill 2021. [PMID: 34081600 DOI: 10.2196/28005] [Reference Citation Analysis]
63 Garrido I, Liberal R, Macedo G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment Pharmacol Ther. 2020;52:267-275. [PMID: 32402090 DOI: 10.1111/apt.15813] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 31.0] [Reference Citation Analysis]
64 Howden CW, Loomba R. A Message from the Editors. Aliment Pharmacol Ther 2022;55:4-5. [PMID: 34907571 DOI: 10.1111/apt.16701] [Reference Citation Analysis]
65 Fedele D, De Francesco A, Riso S, Collo A. Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview.Nutrition. 2021;81:111016. [PMID: 33059127 DOI: 10.1016/j.nut.2020.111016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
66 Zhao W, Zhang X, Zhu F, Jiang X. Dynamic Changes of Liver Function Indexes in Patients with Different Clinical Types of COVID-19. IJGM 2022;Volume 15:877-84. [DOI: 10.2147/ijgm.s347291] [Reference Citation Analysis]
67 Mansour S, Hallon K, Abramov R, Damouny M, Rufeizen L, Marjiyeh R, Kluger Y, Khuri S. Acute Complicated Pancreatitis With COVID-19 Infection as a Potential Cause. J Med Cases 2021;12:429-32. [PMID: 34804300 DOI: 10.14740/jmc3766] [Reference Citation Analysis]
68 Patel TK, Patel PB, Barvaliya M, Vijayalaxmi, Bhalla HL. Efficacy and safety outcomes with remdesivir in COVID-19 patients: A meta-analysis. World J Meta-Anal 2021; 9(1): 74-87 [DOI: 10.13105/wjma.v9.i1.74] [Reference Citation Analysis]
69 Garrido M, Pereira Guedes T, Alves Silva J, Falcão D, Novo I, Archer S, Rocha M, Maia L, Sarmento-Castro R, Pedroto I. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19. GE Port J Gastroenterol 2021;158:1-12. [PMID: 34192127 DOI: 10.1159/000513593] [Reference Citation Analysis]